Details for New Drug Application (NDA): 010895
✉ Email this page to a colleague
The generic ingredient in NORLUTIN is norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
Summary for 010895
Tradename: | NORLUTIN |
Applicant: | Parke Davis |
Ingredient: | norethindrone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 010895
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription